Here are five highlights:
1. The appointment is for two years.
2. Mr. Flanagan possesses 30-plus years of medical device industry experience.
3. He is the CEO and board of directors’ chairman of DiscGenics, a regenerative medicine company for spine degenerative diseases.
4. Mr. Flanagan also founded Flanagan Instruments, a neurosurgical device distribution company. Itochu International purchased the company in 2005.
5. He serves on the boards of TrueVision Systems and Alliance for Regenerative Medicine.
More articles on spine:
5 key points on cost-effectiveness of perioperative thoracolumbar fracture imaging
Why Dr. Thomas Schuler says arthroplasty, artificial intelligence are the top 2 areas in spine surgery
Essentia Health-Duluth Clinic welcomes spine surgeon Dr. Anne Normand: 4 notes
